# Fosun Pharma Q3 Revenue Exceeds CNY 30 Billion

> Fosun Pharma's first three quarters revenue hits CNY 30.463 billion, with innovative drug revenue up 15.54% year-over-year.
- Title: Fosun Pharma Q3 Revenue Exceeds CNY 30 Billion · BigGo Finance
- Summary: Fosun Pharma's first three quarters revenue hits CNY 30.463 billion, with innovative drug revenue up 15.54% year-over-year. Fosun Pharma reported first three…
- Keywords: fosun pharma, innovative drugs, pharmaceutical business, overseas business, r and d investment, net profit, finance, markets, Fosun, Pharma, Revenue, Exceeds
- Source: BigGo Finance — https://finance.biggo.com/news/8640cd2c-53a7-439d-8dda-c3dfee02123a
- Author: BigGo Finance
- Published: 2026-10-27T15:35:14+00:00
- Read time: 1 min
- Topics: fosun pharma, innovative drugs, pharmaceutical business, overseas business, r and d investment, net profit, finance, markets
## First Three Quarters Revenue
Fosun Pharma reported first three quarters revenue of CNY 30.463 billion, up 3.64% year-over-year.
## Net Profit Growth
Net profit attributable to shareholders rose to CNY 2.667 billion, up 5.71% year-over-year.
## Innovative Drug Revenue
Innovative drug revenue grew 15.54% year-over-year, accounting for 35.43% of pharmaceutical business revenue.
## Overseas Business Expansion
Overseas business revenue grew 11.62% year-over-year, increasing its share of group revenue to 30.96%.
## R&D Investment Surge
Total R&D investment reached CNY 5.247 billion, up 31.24% year-over-year, with innovative drugs accounting for 82.83%.
## Third-Quarter Performance
Third-quarter revenue was CNY 10.02 billion with net profit of CNY 946 million, up 15.18% year-over-year.
## Key takeaway

Fosun Pharma reported first three quarters revenue of CNY 30.463 billion, up 3.64% year-over-year, with innovative drug revenue growing 15.54%.